Hanjun Zhao | Antiviral study | Best Researcher Award

Published on by China Scientist

Prof. Hanjun Zhao | Antiviral study | Best Researcher Award

Professor Hanjun Zhao is a virologist and Professor at Fudan University, with a Ph.D. in Microbiology from The University of Hong Kong. He has held research positions at the University of Hong Kong, served as a Principal Investigator in Hong Kong’s Centre for Virology, and was a visiting researcher at Imperial College London. His research focuses on antiviral therapeutics, nanoparticle-based drug delivery, and vaccine development. With multiple international awards and over a decade of scientific leadership, Professor Zhao is recognized for his innovative contributions to combating influenza, coronaviruses, and emerging infectious diseases.

Prof. Hanjun Zhao | Shanghai Institute of Major Infectious Diseases and Biosafety | China

Profile

ORCID ID

Education

  • Professor Hanjun Zhao received his MBBS degree from the College of Medicine, Anhui University of Science and Technology. He then pursued a Master of Science degree at the School of Life Sciences, Anhui Normal University, which he completed, he earned his Ph.D. in Microbiology from the Department of Microbiology at The University of Hong Kong, establishing a strong academic foundation in virology, immunology, and infectious disease research.

Experience

  • After completing his Ph.D., Professor Zhao began his postdoctoral research fellowship at The University of Hong Kong, continuing until January . During this time, he was deeply engaged in cutting-edge microbiological and virological research. He served as a Research Assistant Professor at the same institution. In parallel, starting from , he has been a Principal Investigator at the Centre for Virology, Vaccinology and Therapeutics in Hong Kong. He also broadened his international research experience as a Visiting Researcher at Imperial College London. As of September, he holds the position of Professor at Fudan University, where he continues to advance his research and mentor future scientists.

Awards and Recognition

  • Professor Zhao has been recognized with numerous prestigious awards throughout his career. He received two Bronze Prizes at the 49th International Exhibition of Inventions of Geneva—one for his work on broad-spectrum antiviral peptides and another for his innovative dual-functional nanoparticle DIG targeting influenza and coronavirus. He was also selected for the Talent Plan of Shanghai Baiyulan. He won first place in the Best Papers Award from Emerging Microbes and Infections , he received the Faculty Outstanding Research Output Award from The University of Hong Kong and was honored with a travel award as a representative of Hong Kong Young Scientists at the World Life Science Conference.

Skills and Certifications

  • Professor Zhao possesses a comprehensive skill set in virology, antiviral drug development, nanoparticle engineering, and immunological assay design. His expertise spans molecular microbiology, viral pathogenesis, and translational therapeutics. He is known for developing broad-spectrum antivirals and functional nanomedicine platforms, which hold promise for combatting emerging infectious diseases. His ability to integrate basic science with applied therapeutic innovation is one of his key strengths.

Research Focus

  • Professor Zhao’s research centers on virology, with a particular emphasis on antiviral strategies and vaccine development. He focuses on the design and functional testing of broad-spectrum antiviral peptides, nanoparticle-based delivery systems, and therapeutic solutions for influenza viruses and coronaviruses. As a Principal Investigator, he is dedicated to exploring the mechanisms of viral infection and immune response, while advancing new approaches in virus-targeted nanomedicine and immunotherapeutics.

Conclusion

  • In conclusion, Professor Hanjun Zhao is a leading expert in virology and antiviral therapeutics, with a strong track record in translational research and international collaboration. His pioneering work on broad-spectrum antiviral agents and nanoparticle-based treatments has earned global recognition and prestigious awards. With a deep foundation in microbiology and a forward-looking approach to infectious disease control, he continues to make significant contributions to global health and biomedical innovation.

Publications

  • Human neutralizing antibodies target a conserved lateral patch on H7N9 hemagglutinin head
    Authors: Manxue Jia, HanJun Zhao, Nicholas C. Morano, Hong Lu, Yin-Ming Lui, Haijuan Du, Jordan E. Becker, Kwok-Yung Yuen, David D. Ho, Peter D. Kwong et al.
    Journal: Nature Communications

  • Allosteric Neutralization by Human H7N9 Antibodies
    Authors: Xueling Wu, Manxue Jia, HanJun Zhao, Nicholas Morano, Hong Lu, Yin-Ming Lui, Haijuan Du, Jordan Becker, Kwok-Yung Yuen, David Ho et al.
    Journal: Preprint (Research Square)

  • Long-term effects of SARS-CoV-2 infection on human brain and memory
    Authors: Qiulu Ding, HanJun Zhao
    Journal: Cell Death Discovery